Judge Axes 1 Tyvaso Patent, Finds Another Was Infringed
A Delaware federal judge has invalidated one of United Therapeutics' drug patents for hypertension drug Tyvaso for lack of enablement, but also held that rival Liquidia's planned generic infringes a different...To view the full article, register now.
Already a subscriber? Click here to view full article